Cardiologist & scientist | Working on cardiovascular health & better outcomes
Joined December 2013
- Tweets 389
- Following 415
- Followers 252
- Likes 755
3 Photos and videos
Raffaele Bugiardini retweeted
🫀Despite successful primary PCI MVO occurs in up to 60% of #STEMI pts & remains a key driver of HF & mortality
Read the new #ESC Clinical Consensus Statement on the Pathophysiology Prevention & Management of Coronary MVO
👉doi.org/10.1093/eurheartj/eh…
@EdinaCenko @ehj_ed @escardio
7
12
803
Raffaele Bugiardini retweeted
❤️Join us on 18 June 2026 (16:00–17:00 CEST) for a FREE @escardio Working Groups Talk co-organised by the @WGCPMChair & @ESCWGAVBChair
🎓 Open to all
🔗 Register: esc365.escardio.org/event/25…
@EdinaCenko @eosto1 @escardio
4
6
70
Raffaele Bugiardini retweeted
May 29
Coronary microvascular obstruction: the "no-reflow" problem that haunts STEMI care. New ESC clinical consensus on pathophysiology, prevention & management: a must-read. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#cardiotwitter @ESC_Journals @escardio
2
91
208
11,908
Raffaele Bugiardini retweeted
May 5
Does physician sex influence CV outcomes?
This article reviews evidence suggesting outcome differences may exist across settings, highlighting possible links to communication, guideline use, and care delivery, while noting the complexity of causality.
academic.oup.com/eurheartj/a…
ALT "Ultimately, these disparities reflect structural inequities within healthcare systems and society. Cardiovascular professionals must remain aware of how their actions can perpetuate these inequities and consciously consider sex, gender, race, and ethnicity when personalizing patient treatment." Edina Cenko, Elena Osto, Roxana Mehran European Heart Journal, 2026
7
14
381
Raffaele Bugiardini retweeted
Apr 20
Rethink beta-blockers for uncomplicated hypertension?
Our @HyperAHA commentary: despite guideline upgrades evidence for routine use in uncomplicated cases is limited
👉 tinyurl.com/ye2yav25
4
4
55
Raffaele Bugiardini retweeted
Apr 20
Upcoming online talk on a relevant topic
Register for free 👇
🔗 esc365.escardio.org/event/26…
@WGCPMChair @escardio @ItaloPorto2 @SIC_CARDIOLOGIA
Persistent angina after revascularisation? 🫀
Join the @escardio #WGCPM_ESC & WGCARE_ESC for a free webinar on Residual vs. Refractory Angina
Explore strategies for your toughest cases
📅 29 May | 16:00 CEST
🔗 esc365.escardio.org/event/26…
@EdinaCenko @ItaloPorto2 @RiSanz2020
3
3
59
Raffaele Bugiardini retweeted
Persistent angina after revascularisation? 🫀
Join the @escardio #WGCPM_ESC & WGCARE_ESC for a free webinar on Residual vs. Refractory Angina
Explore strategies for your toughest cases
📅 29 May | 16:00 CEST
🔗 esc365.escardio.org/event/26…
@EdinaCenko @ItaloPorto2 @RiSanz2020
4
5
134
Raffaele Bugiardini retweeted
Physician sex may impact CV outcomes?
We must adopt practices that save lives: better communication, bias awareness, diverse clinical teams & leadership
Read more: doi.org/10.1093/eurheartj/eh…
@EdinaCenko @ESCWGAVBChair @WGCPMChair @Drroxmehran @escardio @WomenAs1
7
11
2,669
Raffaele Bugiardini retweeted
Mar 27
Women’s heart health remains at risk as gaps in sex-specific research, male-focused diagnostics, and low trial enrollment contribute to underdiagnosis and undertreatment.
Sex-specific studies are vital to advance care and equity in cardiology.
Read more: academic.oup.com/eurheartj/a…
ALT Ischaemic heart disease: sex and gender differences Risk profile Anatomy and pathophysiology • Unbalanced weight of some risk factors • More biological changes in females in adult life Anatomy and pathophysiology • Sex-related structural and functional differences of the coronary circulation • Sex-related differences of obstructive vs non-obstructive CAD Diagnosis • Differences in symptoms • Male centric bias evaluation • Delay and underdiagnosis in females Prognosis and outcome • Differences in response and side effects to some treatments • Age-related differences • Findings from RCTs not fully generalizable to females Bridging the gap • Awareness • Education • Research • Patient involvement • Policy changes • Equal enrollment in RCTs and dedicated RCTs Horizontal and vertical equity in health care CAD, coronary artery disease, RCT, randomized controlled trial Manfrini O, et al. European Heart Journal
14
27
524
A new article in the European Heart Journal highlights an important dimension of cardiovascular care: “Cardiovascular disease outcomes: does physician’s sex matter?” Click on the link to learn more about this interesting topic!
academic.oup.com/eurheartj/a…
6
8
187
Raffaele Bugiardini retweeted
💡 New #WGCPM_ESC Newsletter
@arturocesaro Prof Paolo Calabrò & @vincenzoacerbo on the PPG Global Registry
Predictive physiology > anatomy
📉 PPG (0=diffuse 1=focal) predicts PCI success:
✅ Post-PCI FFR & 1-yr TVF
✅ Detects “physiological futility”
👉tinyurl.com/2zxy3zww
5
8
253
Raffaele Bugiardini retweeted
Feb 4
Grouping risk factors masks danger?
New data in #EHJCCO: Diabetes drives 30-day ACS mortality but lumping factors dilute the risk
Risk 40% Men 29% #women
👉tinyurl.com/4bbnajp5
Individualized assessment is key
#ISACS @OliviaManfrini @RBugiardini @EdinaCenko @maria_bergami
5
6
165
Raffaele Bugiardini retweeted
New #WGCPM_ESC #ACVC_ESC #EAPCI statement on #sex & #gender differences in #IHD, including high-risk cardiogenic shock & emerging topics like gender-affirming therapies & CV risk
👉 tinyurl.com/yda4cmxc
@ehj_ed @escardio @EdinaCenko @EAPCIPresident @ACVCPresident
7
16
1,389
Raffaele Bugiardini retweeted
Sex and gender differences in coronary pathophysiology and ischaemic heart disease: A Scientific Statement of the ESC Working Group on Coronary Pathophysiology & Microcirculation, the Association for Acute CardioVascular Care, and the European Association of Percutaneous Cardiovascular Interventions of the ESC: @ESC_Journals
👇👇👇
1
12
30
1,959
Raffaele Bugiardini retweeted
Jan 26
New ESC Scientific Statement sheds light on how sex and gender shape coronary disease risk, symptoms, diagnosis, and treatment, highlighting gaps in research and care and calling for more equitable heart health for all. Read more in #EHJ. doi.org/10.1093/eurheartj/eh…
#cardiotwitter @ESC_Journals @escardio
20
55
2,868
Raffaele Bugiardini retweeted
29 Dec 2025
“To address inequalities & disparities in #cardiovascular health among disadvantaged populations, @LancetRH_Europe has launched a pivotal Commission dedicated to addressing these issues..”
@PoojaJha2015 @RBugiardini @EdinaCenko @DrMarthaGulati
sciencedirect.com/science/ar…
4
23
1,276
Raffaele Bugiardini retweeted
27 Dec 2025
Challenges in the prevention, treatment & management of cardiovascular disease among older adults.
One of the many articles from our @LancetRH_Europe series….
@RBugiardini @DrMarthaGulati @EdinaCenko
thelancet.com/journals/lanep…
4
16
72
6,140
Raffaele Bugiardini retweeted
27 Dec 2025
❤️In #MINOCA, risk stratification should inform secondary prevention, not therapeutic nihilism.
Future research must focus on mechanism-driven integrated approaches
👉🔗 doi.org/10.1161/JAHA.125.046…
@JAHA_AHA @EdinaCenko @RBugiardini @OliviaManfrini @WGCPMChair
4
7
81
Raffaele Bugiardini retweeted
27 Dec 2025
🫀 In #MINOCA integrated physiology and imaging are essential for risk stratification and mechanism-guided therapy
🔗 doi.org/10.1161/JAHA.125.046…
#RiskStratification #Cardiology
@JAHA_AHA @RBugiardini @OliviaManfrini @EdinaCenko @WGCPMChair
ALT https://www.ahajournals.org/doi/10.1161/JAHA.125.046933
3
6
98
Raffaele Bugiardini retweeted
10 Dec 2025
❤️At the #SIC2025 Congress in Rome the Joint Symposium by @SIC_CARDIOLOGIA & @TheLancetRegHE offered powerful insights on advancing equity in #CVHealth
👏Thanks to all for driving this conversation!
@EdinaCenko @RBugiardini @PoojaJha2015 @DrMarthaGulati @CVR_TomaszGuzik
1
5
7
967